St. Louis Startup Spearhead Bio Raised $1.62 Million
The biotech firm secured seed funding to adapt its plant gene-editing technology for commercial agricultural use.
Updated on Sept. 22, 2026 in Biotech
Live Poll
Do you support the use of gene editing technology to develop new agricultural crop traits?
St. Louis-based Spearhead Bio has raised $1.62 million in a seed funding round. The company will use the new capital to scale its gene-editing platform for agricultural pipelines.
Why it matters
The investment provides critical runway for the startup to transition its scientific research into commercial agricultural applications over the next two years. It marks a significant milestone for the firm as it moves beyond its roots as a spinout from the Donald Danforth Plant Science Center.
The startup utilizes transposable elements in tandem with CRISPR to facilitate larger gene edits in plant genomes. This process is designed to overcome limitations in existing gene-editing tools by enabling more complex genetic modifications.
The players
Spearhead Bio
This St. Louis-based biotech company specializes in advancing agricultural gene-editing technologies.
Donald Danforth Plant Science Center
This is a non-profit research institution based in Missouri focused on plant science and agricultural innovation.
BioGenerator Ventures
This organization focuses on building and investing in innovative biotech and healthcare startups in the St. Louis region.
The details
The round was structured as a Simple Agreement for Future Equity and was led by BioGenerator Ventures and the Danforth Technology Company. Participation also included QRM Capital, Grit Road Partners, the St. Louis Port Authority Helix Fund, and SDH Capital.
Timeline
Spearhead Bio spun out of the Donald Danforth Plant Science Center in 2025.
The firm received a National Science Foundation Small Business Technology Transfer Phase I grant in 2025.
The company announced the closing of its seed funding round in September 2026.
The Tech Race
The company's expansion into commercial agricultural pipelines reflects the broader race to integrate advanced genomic tools like CRISPR into large-scale farming. This shift replaces traditional, slower breeding methods with precise, scalable gene-editing technology.
For the agricultural sector, this technology could eventually lead to crops with higher yields or improved resilience to environmental stressors. Users and growers should look for future announcements regarding which specific crops the company plans to introduce to the commercial market.
The takeaway
This funding provides the startup with 18 to 24 months of operational runway to prove its gene-editing platform can work at an industrial scale. Investors and ag-tech observers are now focused on how effectively the firm translates its laboratory research into field-ready products.
Further reading
Learn more about the local innovation ecosystem in the Biotech section.
Source note: This article includes information reported by St. Louis Magazine.
Live Poll
Do you support the use of gene editing technology to develop new agricultural crop traits?
